Evelo Biosciences, Inc. (EVLO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Craig R. Jalbert CIRA
|
President, Secretary, Principal Executive, Financial and Accounting Officer & Director | -- | -- | 1962 |
|
Dr. Chun Zhang Ph.D.
|
Chief Technical Operations & Quality Officer | -- | -- | -- |
|
Ms. Leslie Wardwell-Scott Ph.D.
|
VP and Head of Corporate Development & Strategic Integration | -- | -- | -- |
|
Dr. Andrea Itano Ph.D.
|
Head of Research | -- | -- | -- |
|
Dr. Duncan McHale M.D., MBBS, Ph.D.
|
Chief Medical Officer | 661.97k | -- | 1966 |
|
Mr. Douglas Maslin
|
Senior Director & Immunology Clinical Lead | -- | -- | -- |
Evelo Biosciences, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 66
Description
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriasis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 15, 2023 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
